Fibrillary Glomerulonephritis in a Patient with Concurrent Diabetic Nephropathy and Misleading Serology: Importance of Tissue Diagnosis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0698; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Empiric prednisone 40 mg daily was initiated at presentation, followed by rituximab 1g for 2 doses given 15 days apart after biopsy confirmation. Biopsy revealed FGN, carrying distinct therapeutic implications unidentifiable on clinical grounds alone. Concurrent diabetic nephropathy further renders proteinuria an unreliable standalone treatment endpoint, reinforcing that biopsy-proven diagnosis must anchor both therapeutic rationale and response monitoring."
Clinical • Cardiovascular • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Fibrosis • Glomerulonephritis • Hypertension • Immunology • Lupus Nephritis • Metabolic Disorders • Monoclonal Gammopathy • Nephrology • Renal Disease
|
|
Sourabh Bidhan; Ragibe Gulsah Dilaver; Paisit Paueksakon; Neil S. Sanghani
|